A multicenter study aiming to create evidence for clinical biomarkers in autoimmune retinopathy
- Conditions
- autoimmune retinopathy
- Registration Number
- JPRN-UMIN000046423
- Lead Sponsor
- Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 220
Not provided
[Patinet with autoimmune retinopathy] (1) uveitis with specific cause (2) inherited retinal diseases (3) optic nerve disorders (4) opacification in anterior segment of the eye and/or optic media which precludes fundus assessment (5) drug-induced retinal disorders (6) aged younger than 20 years (7) patinet who disagrees with this study (8) patinet who the attending doctor judges as ineligibile to participate in this study [Healthy volunteer] Individual who disagrees with this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change in best-corrected visual acuity improvement from baseline to 6 months
- Secondary Outcome Measures
Name Time Method the following parameters during 6-month follow-up: (1) change in visual field from baseline to 6 months (2) change in optical coherence tomography findings (3) change in comprehenisive protein array data from blood samples (4) change in metabolome profile from blood samples (5) difference in comprehenisive protein array data from blood samples between patinets with autoimmune retinopathy and healthy volunteers (6) difference in metabolome profile from blood samples between patinets with autoimmune retinopathy and healthy volunteers (7) adverse events